Why Biotechnology Investing is Looking Healthy
ETF Trends publisher Tom Lydon discussed SPDR S&P Biotech ETF (NYSEArca:XBI) on this week’s “ETF of…
Browsing: Biotechnology
Drug Makers, Pharma ETFs Face a Tough Earnings Season
The healthcare sector has been lackluster this earnings season, and without supporting factors such as…
Valuations Rising For Semiconductor ETFs
Technology stocks and the corresponding exchange traded funds have been key drivers of the bullishness…
Biotech Stocks Celegene, Gilead Could Boost IBB
The iShares Nasdaq Biotechnology ETF (NasdaqGM: IBB), the largest biotechnology exchange traded fund by assets,…
Upside Coming for Biotech ETFs Against Challenging Political Backdrop
The iShares Nasdaq Biotechnology ETF (NasdaqGM: IBB), the largest biotechnology exchange traded fund by assets,…
Why Biotech ETFs Are a Better Bet Than Healthcare
The iShares Nasdaq Biotechnology ETF (NasdaqGM: IBB), the largest biotechnology exchange traded fund by assets,…
Third-Largest Biotech ETF Up 20% Year-to-Date
After slumping last year, the SPDR S&P Biotech ETF (NYSEArca: XBI), the third-largest biotechnology exchange…
Another Endorsement for a Big Biotech ETF
After disappointing investors last year, the iShares Nasdaq Biotechnology ETF (NasdaqGM: IBB), the largest biotechnology…
Alternative ETF Options to Hedge Trump Risk on Obamacare
After Republicans unveiled their Obamacare replacement, healthcare and biotechnology-related sectors were none too pleased. Nevertheless,…
ETF Performance Report: February 2017
U.S. equities and stock exchange traded funds ended February on a sullen note, with the…
Traders Turn Bullish on Beloved Biotech ETFs
The iShares Nasdaq Biotechnology ETF (NasdaqGM: IBB), the largest biotechnology exchange traded fund by assets,…
A Biotech ETF Gets Its Groove Back
After struggling through one of its worst annual performances in several years in 2016, the…
Biotech ETFs can Cope With the new White House
The healthcare sector was a laggard last year, but the iShares Nasdaq Biotechnology ETF (NasdaqGM:…
Healthcare ETFs Are Latest Victim to Trump
Healthcare stocks, especially the biotech segment, and related exchange traded funds plunged Wednesday after President-elect…